Mitchell Kamrava

Papers

Total Citations

144

H-Index

About

Mitchell Kamrava is a leading figure in radiation oncology whose research centers on optimizing treatment for prostate cancer through cost-effective, patient-centered approaches. His landmark work, "Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer" (2015, 144 citations), introduced a transformative methodology for healthcare economics. By applying time-driven activity-based costing (TDABC), Kamrava provided the first detailed, phase-by-phase cost analysis of competing treatments—such as active surveillance, surgery, and radiation—for low-risk prostate cancer. This contribution has been pivotal in helping clinicians and policymakers weigh clinical efficacy against financial sustainability, directly influencing value-based care models. Beyond this seminal paper, Kamrava has advanced stereotactic body radiotherapy (SBRT) and brachytherapy techniques, earning recognition for improving precision while reducing toxicity. His work bridges oncology, health policy, and operational efficiency, making him a key voice in discussions on resource allocation in cancer care. For students and researchers, Kamrava exemplifies how rigorous cost analysis can reshape treatment paradigms without compromising outcomes.